Total Payments
$545.46
2024 Payments
$186.68
Companies
9
Transactions
27
Medicare Patients
4,381
Medicare Billing
$287,131
Payment Breakdown by Category
Food & Beverage$545.46 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $545.46 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $189.15 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $155.43 | 8 | $0 (2024) |
| Lilly USA, LLC | $85.48 | 4 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $31.89 | 2 | $0 (2023) |
| Amarin Pharma Inc. | $19.78 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $17.47 | 1 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $15.65 | 1 | $0 (2024) |
| PFIZER INC. | $15.60 | 1 | $0 (2024) |
| Corcept Therapeutics | $15.01 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $186.68 | 10 | AstraZeneca Pharmaceuticals LP ($155.43) |
| 2023 | $316.45 | 16 | Amneal Pharmaceuticals LLC ($146.82) |
| 2022 | $42.33 | 1 | Amneal Pharmaceuticals LLC ($42.33) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Respiratory | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Respiratory | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Respiratory | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Respiratory | ||||||
| 10/13/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: VACCINES | ||||||
| 10/13/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/06/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: NEUROLOGY | ||||||
| 09/09/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/31/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Diabetes | ||||||
| 07/18/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROLOGY | ||||||
| 06/30/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: NEUROLOGY | ||||||
| 06/30/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: NEUROLOGY | ||||||
| 06/28/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Endocrinology | ||||||
| 06/19/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Neuroscience | ||||||
| 06/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Diabetes | ||||||
| 05/26/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardiovascular | ||||||
| 05/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 667 | 753 | $218,776 | $42,283 |
| 2022 | 11 | 1,361 | 1,628 | $409,146 | $95,868 |
| 2021 | 12 | 1,552 | 1,820 | $431,690 | $97,871 |
| 2020 | 11 | 801 | 825 | $186,410 | $51,109 |
Total Patients
4,381
Total Services
5,026
Medicare Billing
$287,131
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 172 | $43,600 | $15,888 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 143 | $47,476 | $9,388 | 19.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 123 | 141 | $28,764 | $5,524 | 19.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 124 | 141 | $49,350 | $4,881 | 9.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $12,894 | $2,351 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $9,912 | $1,958 | 19.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $4,304 | $744.08 | 17.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 20 | 39 | $9,750 | $632.58 | 6.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 34 | 36 | $9,000 | $583.20 | 6.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 20 | $3,726 | $332.28 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 411 | 544 | $180,608 | $38,738 | 21.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 430 | 537 | $80,550 | $27,229 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 130 | 130 | $53,690 | $11,445 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 83 | $37,680 | $8,306 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $14,122 | $2,874 | 20.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 50 | 54 | $11,016 | $2,497 | 22.7% |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | Office | 2022 | 135 | 156 | $5,616 | $1,835 | 32.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 43 | 43 | $15,050 | $1,489 | 9.9% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2022 | 18 | 18 | $814.14 | $803.34 | 98.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 21 | 21 | $5,250 | $342.97 | 6.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 18 | 19 | $4,750 | $309.15 | 6.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 502 | 689 | $137,800 | $38,449 | 27.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 298 | 298 | $89,400 | $21,864 | 24.5% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 319 | 367 | $110,100 | $15,145 | 13.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 192 | 219 | $49,350 | $7,737 | 15.7% |
About Antonio King, PAC
Antonio King, PAC is a Medical healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1154660637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Antonio King, PAC has received a total of $545.46 in payments from pharmaceutical and medical device companies, with $186.68 received in 2024. These payments were reported across 27 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($545.46).
As a Medicare-enrolled provider, King has provided services to 4,381 Medicare beneficiaries, totaling 5,026 services with total Medicare billing of $287,131. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Brooklyn, NY
- Active Since 02/04/2013
- Last Updated 05/09/2017
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154660637
Products in Payments
- LYVISPAH (Drug) $189.15
- AIRSUPRA (Drug) $138.03
- MOUNJARO (Drug) $37.29
- XYOSTED (Drug) $31.89
- JARDIANCE (Drug) $25.29
- EMGALITY (Drug) $22.90
- Vascepa (Drug) $19.78
- SHINGRIX (Biological) $17.47
- BREZTRI (Drug) $17.40
- NUPLAZID (Drug) $15.65
- PAXLOVID (Drug) $15.60
- Korlym (Drug) $15.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Brooklyn
Carl Clarke, Rpa-C, RPA-C
Medical — Payments: $115,985
Medical $115,985
Catherine Sekansky, Pa-C, PA-C
Medical — Payments: $20,836
Medical $20,836
Mr. Phillip Scotti, Pa-C, PA-C
Medical — Payments: $20,375
Medical $20,375
Vita Oklander, Pa-C, PA-C
Medical — Payments: $11,352
Medical $11,352
Ms. Anna Gorelik, P.a, P.A
Medical — Payments: $10,453
Medical $10,453
Mrs. Margret Levin, Pa-C, PA-C
Medical — Payments: $9,718
Medical $9,718